# Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants

> **NCT02334982** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 47 (actual)

## Conditions studied

- Dose Finding Study

## Interventions

- **DRUG:** TAK-137
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02334982
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02334982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02334982, "Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02334982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*